Haw. Code R. § 16-92-25.1

Current through September, 2024
Section 16-92-25.1 - Requirements for therapeutic certification

Each applicant for therapeutic certification shall hold a current and unencumbered license, with certification to use DPAs, and submit documentation of successful completion of the following requirements:

(1) A one hundred hour board approved course in the treatment and management of ocular diseases prepared and graded by an accredited school of optometry, provided that an applicant who graduated from an accredited optometric college, school, or university after January 1, 1997, may satisfy the course requirement by submitting written verification from the optometric college, school, or university that the applicant has satisfactorily completed at least one hundred hours of education in the treatment and management of ocular diseases. Board approval of the course includes, but is not limited to:
(A) Favorable evaluation of the applicant's official transcripts, as related to the course in the treatment and management of ocular diseases, issued by an accredited school of optometry;
(B) The provision of written verification from the accredited school of optometry that the applicant has satisfactorily completed the course; and
(C) Any other such criteria, as determined and approved by the board;
(2) The NBEO Treatment and Management of Ocular Disease examination, provided that an applicant who has completed the NBEO Part II (Clinical Science) examination after January 1, 1993, shall be considered to have passed the NBEO Treatment and Management of Ocular Disease examination; and
(3) One hundred hours of preceptorship acquired under the supervision of an ophthalmologist after July 2, 1997, which included training in the diagnosis, treatment, and management of ocular diseases, and is verified by the supervising ophthalmologist on a form and format prescribed by the board.

Haw. Code R. § 16-92-25.1

[Eff and comp 7/23/99; comp 6/3/02; comp 11/1/10] (Auth: HRS §§ 459-4, 459-7.4) (Imp: HRS §§ 459-7.4, 459-8)